Marker Therapeutics Inc (MRKR)

[attilathehunt]

I am a strong believer in the science and tend to (understatement) hype the results. In all fairness, if the news/results are flat, I expect we could go back to under $6. Perhaps under $5 if the shorts attempt to drive it down with the downward momentum. If that happens, it will be a gift since results later this year should exceed current SOC. In any event, I expect the share price to rise (and stick) with each trial update.

IMO, the shelf is the big unknown and I believe we will get some clarity on it on Monday’s (22nd) stakeholders conference call.